CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Apures Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Apures Co Ltd
44, Hansan-gil, Cheongbuk-eup
Phone: +82 316830643p:+82 316830643 PYEONGTAEK, 17792  South Korea Ticker: 149300149300
Business Summary
APURES CO., LTD. is a Korea-based company mainly engaged in development and distribution of mini pigs used for medical treatment and experiment. The Company sells experimental animals used for nonclinical research under the brand name of MICROPIG. The Company’s mini pigs are used for pharmaceuticals, regenerative medicine, xenotransplantation research, development of organ transplant medical equipment and medical technology, as well as other biotechnology fields. In addition, the Company sells bio resources, bio materials and biological agents used for body and tissue engineering.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
0213 Hogs
8731 Commercial physical and biological research
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Seon DeokChoi 54
Internal Auditor Seong SuOh 50 3/1/2019 3/1/2019
Director Seong GonAhn 47 2/1/2017 2/1/2017
Non-Executive Independent Director Won JungYoon 77 3/1/2019 3/1/2019

General Information
Number of Employees: 30 (As of 12/31/2023)
Outstanding Shares: 43,486,252 (As of 12/31/2023)
Shareholders: 1,865
Stock Exchange: KON
Fax Number: +82 316832315


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024